Table 2—

Demographical characteristics study population

AsthmaCOPD
N879631
Age yrs44.2±0.764.3±0.5*
M/F2.37.3*
BMI kg·m224.2±0.225.4±0.2*
Smokers %33.3100*
Tobacco smoking pack-yrs19.5±1.141.0±0.8*
VAS 0–10034.6±0.948.3±1.0*
PEFR
 L·min−1300.0±4.5234.6±4.7*
 %67.7±0.853.6±0.9*
FEV1
 L2.3±0.01.6±0.0*
 %75.7±0.858.2±1.0*
FEV1/VC
 L71.9±0.558.4±0.7*
 %117.2±1.286.5±1.2*
TLC
 L5.0±0.15.7±0.1*
 %92.1±0.993.6±1.2
Per cent increase #13.9±0.812.5±0.9
Pa,O2 mmHg 78.1±1.170.9±0.7*
Pa,CO2 mmHg+38.8±0.641.1±0.4*
  • Data are presented as mean±sd

  • BMI: body mass index

  • VAS: visual analogue scale

  • PEFR: peak expiratory flow rate

  • FEV1: forced expiratory volume in one second

  • VC: vital capacity

  • TLC: total lung capacity

  • Pa,O2: oxygen tension in arterial bood

  • Pa,CO2: carbon dioxide tension in arterial blood

  • #: Data are % increase in FEV1 from baseline after inhalation of bronchodilators

  • : n=45

  • +: n=112

  • *: p<0.0001 for the comparison between asthma and chronic obstructive pulmorary disease patients (COPD)